JP2022543320A5 - - Google Patents

Info

Publication number
JP2022543320A5
JP2022543320A5 JP2022507761A JP2022507761A JP2022543320A5 JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5 JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5
Authority
JP
Japan
Prior art keywords
seq
complex according
complex
peptide carrier
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543320A (ja
JP7678654B2 (ja
Filing date
Publication date
Priority claimed from GBGB1911403.2A external-priority patent/GB201911403D0/en
Application filed filed Critical
Publication of JP2022543320A publication Critical patent/JP2022543320A/ja
Publication of JP2022543320A5 publication Critical patent/JP2022543320A5/ja
Application granted granted Critical
Publication of JP7678654B2 publication Critical patent/JP7678654B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507761A 2019-08-09 2020-08-07 複合体及びその使用 Active JP7678654B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1911403.2 2019-08-09
GBGB1911403.2A GB201911403D0 (en) 2019-08-09 2019-08-09 Conjugate and uses thereof
PCT/GB2020/051891 WO2021028666A1 (en) 2019-08-09 2020-08-07 Conjugate and uses thereof

Publications (3)

Publication Number Publication Date
JP2022543320A JP2022543320A (ja) 2022-10-11
JP2022543320A5 true JP2022543320A5 (cg-RX-API-DMAC7.html) 2023-08-14
JP7678654B2 JP7678654B2 (ja) 2025-05-16

Family

ID=67990936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507761A Active JP7678654B2 (ja) 2019-08-09 2020-08-07 複合体及びその使用

Country Status (13)

Country Link
US (1) US20220275372A1 (cg-RX-API-DMAC7.html)
EP (1) EP4010030A1 (cg-RX-API-DMAC7.html)
JP (1) JP7678654B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220079524A (cg-RX-API-DMAC7.html)
CN (2) CN114615998B (cg-RX-API-DMAC7.html)
AU (1) AU2020327659A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022002309A2 (cg-RX-API-DMAC7.html)
CA (1) CA3149700A1 (cg-RX-API-DMAC7.html)
GB (1) GB201911403D0 (cg-RX-API-DMAC7.html)
IL (1) IL290424A (cg-RX-API-DMAC7.html)
MX (1) MX2022001712A (cg-RX-API-DMAC7.html)
SA (1) SA522431627B1 (cg-RX-API-DMAC7.html)
WO (1) WO2021028666A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018150196A1 (en) 2017-02-17 2018-08-23 Oxford University Innovation Limited Cell penetrating peptides modified by glycosylation
GB201812972D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
GB201812980D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
AU2019394177A1 (en) * 2018-12-07 2021-06-10 Oxford University Innovation Limited Linkers
CA3211038A1 (en) 2021-02-12 2022-08-18 Oxford University Innovation Limited Cell-penetrating peptide conjugates and methods of their use
US20240189434A1 (en) * 2021-03-12 2024-06-13 Pepgen Inc. Methods of treating myotonic dystrophy type 1 using peptide-oligonucleotide conjugates
IL321025A (en) * 2022-11-21 2025-07-01 Pepgen Inc Cell-penetrating peptides, conjugates thereof, and methods of their use
EP4759826A1 (en) * 2023-08-07 2026-06-17 Toagosei Co., Ltd. Peptide fragment and use thereof
WO2025033255A1 (ja) * 2023-08-07 2025-02-13 東亞合成株式会社 ペプチドフラグメント及びその利用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6047270B2 (ja) * 2006-08-11 2016-12-21 バイオマリン テクノロジーズ ベー.フェー. Dnaリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段
CA2691673A1 (en) 2007-06-29 2009-01-08 Avi Biopharma, Inc. Tissue specific peptide conjugates and methods
US20100016215A1 (en) * 2007-06-29 2010-01-21 Avi Biopharma, Inc. Compound and method for treating myotonic dystrophy
WO2009147368A1 (en) * 2008-06-04 2009-12-10 Medical Research Council Peptides
US20110269665A1 (en) * 2009-06-26 2011-11-03 Avi Biopharma, Inc. Compound and method for treating myotonic dystrophy
WO2013030569A2 (en) * 2011-08-30 2013-03-07 Michael John Gait Peptides
US10111962B2 (en) 2012-09-25 2018-10-30 Genzyme Corporation Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy
RU2708237C2 (ru) 2014-08-22 2019-12-05 Общество с ограниченной ответственностью "НооГен" Модифицированные олигонуклеотиды и способ их получения

Similar Documents

Publication Publication Date Title
JP2021534131A5 (cg-RX-API-DMAC7.html)
US8609065B2 (en) Molecules for targeting compounds to various selected organs, tissues or tumor cells
CA2846218C (en) Cell-penetrating peptides having a central hydrophobic domain
US20220090066A1 (en) Cell penetrating molecule
JP4974890B2 (ja) ペプチドが結合された、イノシン置換アンチセンスオリゴマー化合物および方法
Tung et al. Preparation and applications of peptide− oligonucleotide conjugates
JP7678654B2 (ja) 複合体及びその使用
WO2023026994A1 (ja) ヒトトランスフェリンレセプター結合ペプチド-薬物コンジュゲート
JP7846169B2 (ja) 細胞透過性ペプチド
WO1997012912A1 (fr) Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
JP2025508337A5 (cg-RX-API-DMAC7.html)
GB2563964A (en) Cell penetrating peptides
RU2022105559A (ru) Конъгат и его применения
WO2001027261A2 (en) Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino
US20230399378A1 (en) Peptide-based delivery of agents
ES2465569T3 (es) Proteína de fusión de melusina recombinante como agente farmacológico en el tratamiento de patologías cardiacas y composiciones de la misma
RU2025116420A (ru) Проникающие в клетку пептиды, их конъюгаты и способы их применения
HK40075520B (en) Conjugate and uses thereof
US20210024583A1 (en) Compositions and methods for peptide mediated oligonucleotide delivery to the central nervous system
WO2025229308A1 (en) Conjugate for treating repeat expansion disorders
RU2023123089A (ru) Проникающие в клетки пептидные конъюгаты
HK40075520A (zh) 缀合物及其用途
RU2021105152A (ru) Проникающие в клетку пептиды
NZ582522A (en) A conjugate comprsing the amino acid sequence LPWKPLG for targeting compounds to brain cells, neuronal cells or tumour cells of neuronal or neuroectodermal origin
Wei Design, synthesis and properties of polyarginine-oligonucleotide conjugates and polyarginine-bridged oligonucleotide pairs